Study
Regular use of low-dose aspirin appears to lower the risk of colorectal cancer in seniors, but caution is needed with high doses.
In plain language
Recent research has found that regular use of low-dose aspirin may lower the risk of colorectal cancer in seniors. The study combined results from many different research efforts and showed a 15% reduction in the risk of colorectal cancer. However, the study also found that using aspirin frequently or in high doses might increase the risk of lung and prostate cancer. This suggests that while aspirin can be helpful for some, it should be used with caution, especially at higher doses. These findings highlight the importance of discussing medication use with healthcare providers to tailor decisions to individual health needs.
Use the full description to understand the study design, methods, and the limits of the findings.
This meta-analysis examines the relationship between regular aspirin use and risk of common cancers. The study synthesizes data from cohort studies to evaluate aspirin's potential role in cancer prevention and identify which populations might benefit most.
Open the original publication for the complete methods, outcomes, and source material.
Published December 2025
Opens at the publisher · external site · may require institutional access
The study provides a strong synthesis of existing evidence on aspirin use and cancer risk, particularly relevant to older adults. While the meta-analysis design offers robust evidence, the reliance on cohort studies introduces some limitations. Overall, the study is methodologically sound and relevant to the senior population.
| Category | Score | Rating |
|---|---|---|
| Study Design / Evidence Level | 8.0/10 | |
| Bias & Methods | 7.0/10 | |
| Statistical Integrity | 8.0/10 | |
| Transparency | 8.0/10 | |
| Conflict of Interest Disclosure | 9.0/10 | |
| Replication / External Validation | 7.0/10 | |
| Relevance to Seniors | 9.0/10 | |
| Journal Quality | 8.0/10 |
The study's conclusions are consistent across included studies, but the non-definitive nature of the results suggests further research is needed to establish causality.
Build a personalized plan using research-backed studies, conditions, and treatments.